Clinical Trial

Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults

Name: Mexidol® Efficacy and Safety in Treatment of VCIND in Older Adults — clinical trial record (NCT07700615)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Completed Phase 4

View on ClinicalTrials.gov →

Summary

The primary objective of this study is to evaluate the efficacy of Mexidol® sequential parenteral and oral administration as part of comprehensive therapy in older adults with chronic brain ischemia and vascular cognitive impairment, no dementia (VCIND).

Trial Details

NCT Number	NCT07700615
Lead Sponsor	Pharmasoft
Conditions	Vascular Cognitive Impairment no Dementia
Enrollment	120 participants
Start Date	2025-09-14
Primary Completion	2025-11-05 (estimated)
Study Completion	2025-11-05 (estimated)
Updated on ClinicalTrials.gov	2026-07-14